Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients
Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status...
Saved in:
| Published in | PloS one Vol. 12; no. 4; p. e0174760 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
06.04.2017
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML.
Using the California Cancer Registry, we performed a retrospective, population-based study of patients ≥15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed.
No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients ≥60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients ≥60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001).
Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. |
|---|---|
| AbstractList | Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Using the California Cancer Registry, we performed a retrospective, population-based study of patients [greater than or equal to]15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients [greater than or equal to]60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients [greater than or equal to]60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. INTRODUCTIONIdentifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML.METHODSUsing the California Cancer Registry, we performed a retrospective, population-based study of patients ≥15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed.RESULTSNo treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients ≥60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients ≥60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001).CONCLUSIONSOlder age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Using the California Cancer Registry, we performed a retrospective, population-based study of patients ≥15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients ≥60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients ≥60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Methods Using the California Cancer Registry, we performed a retrospective, population-based study of patients ≥15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. Results No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients ≥60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients ≥60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65–0.98); AML, RR = 0.86 (95% CI = 0.75–0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18–0.89); AML, RR = 0.60 (95% CI = 0.44–0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92–0.99); AML, RR = 0.94 (95% CI = 0.90–0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47–0.71); AML, RR = 0.80 (95% CI = 0.70–0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Conclusions Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML.Using the California Cancer Registry, we performed a retrospective, population-based study of patients ≥15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed.No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients ≥60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients ≥60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001).Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Methods Using the California Cancer Registry, we performed a retrospective, population-based study of patients [greater than or equal to]15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. Results No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients [greater than or equal to]60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients [greater than or equal to]60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Conclusions Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Methods Using the California Cancer Registry, we performed a retrospective, population-based study of patients ≥15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. Results No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients ≥60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients ≥60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariate-adjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65–0.98); AML, RR = 0.86 (95% CI = 0.75–0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.18–0.89); AML, RR = 0.60 (95% CI = 0.44–0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92–0.99); AML, RR = 0.94 (95% CI = 0.90–0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47–0.71); AML, RR = 0.80 (95% CI = 0.70–0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Conclusions Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations. |
| Audience | Academic |
| Author | Jabo, Brice Morgan, John W Wieduwilt, Matthew J Martinez, Maria Elena Ghamsary, Mark |
| AuthorAffiliation | 2 University of California San Diego, Moores Cancer Center, La Jolla, California, United States of America University of Kentucky, UNITED STATES 1 Loma Linda University School of Public Health, Loma Linda, California, United States of America |
| AuthorAffiliation_xml | – name: University of Kentucky, UNITED STATES – name: 2 University of California San Diego, Moores Cancer Center, La Jolla, California, United States of America – name: 1 Loma Linda University School of Public Health, Loma Linda, California, United States of America |
| Author_xml | – sequence: 1 givenname: Brice surname: Jabo fullname: Jabo, Brice organization: Loma Linda University School of Public Health, Loma Linda, California, United States of America – sequence: 2 givenname: John W surname: Morgan fullname: Morgan, John W organization: Loma Linda University School of Public Health, Loma Linda, California, United States of America – sequence: 3 givenname: Maria Elena surname: Martinez fullname: Martinez, Maria Elena organization: University of California San Diego, Moores Cancer Center, La Jolla, California, United States of America – sequence: 4 givenname: Mark surname: Ghamsary fullname: Ghamsary, Mark organization: Loma Linda University School of Public Health, Loma Linda, California, United States of America – sequence: 5 givenname: Matthew J orcidid: 0000-0002-5414-9228 surname: Wieduwilt fullname: Wieduwilt, Matthew J organization: University of California San Diego, Moores Cancer Center, La Jolla, California, United States of America |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28384176$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1uL1TAQx4usuBf9BqIFQfThHJOml-RFWBYvBxYWXPU1TNtpmzVNapOKx6_jFzW1Z5dzZB-kD01mfvPPTCZzGh0ZazCKnlKypqygb27sNBrQ6yGY14QWaZGTB9EJFSxZ5QlhR3vr4-jUuRtCMsbz_FF0nHDGU1rkJ9Hva1spW2Nv2xGGTlVxrdwAo_IKXaxMXHXB5zsM3m0Mpo7DHrwdrEIf6Aq1jv0Ixg0ajAevrIknr7T6tayht6aNoZ60j6GaPMZ62w-dLTW4WWCWXOz9FrVVdaxx-oa9gngICmi8exw9bEA7fLL7n0Vf3r_7fPFxdXn1YXNxfrmqioz7leCVICXSNCENMo5JylLKOCeCB1NJ8yohUIpM1LUghDZpWdOmyTllJRZlSdlZ9HzRHbR1cne_TlLOMyIyKkQgNgtRW7iRw6h6GLfSgpJ_DXZsJYyhKo2SihqxoUywhqaMMA4JKyAvcoFpHVILWm93p01lj3UVKh1BH4geeozqZGt_yNBERrIkCLzaCYz2-4TOy165uR9g0E5L3iJLkmzO-8U_6P3V7agWQgHKNDacW82i8jwVrMjTnM95r--hwhcekarCY2xUsB8EvD4ICIzHn76FyTm5uf70_-zV10P25R7bIWjfOaun-dm5QzBdwGq0zo3Y3F0yJXKepdvbkPMsyd0shbBn-w26C7odHvYHlFwfcw |
| CitedBy_id | crossref_primary_10_1038_s41375_024_02172_3 crossref_primary_10_1182_hematology_2021000259 crossref_primary_10_3892_ol_2019_9966 crossref_primary_10_1182_bloodadvances_2023012469 crossref_primary_10_2217_fon_2017_0599 crossref_primary_10_1002_cam4_4601 crossref_primary_10_1097_HS9_0000000000000652 crossref_primary_10_1016_j_jtct_2023_04_020 crossref_primary_10_1016_j_beha_2023_101480 crossref_primary_10_1200_EDBK_432186 crossref_primary_10_1002_cncr_33826 crossref_primary_10_1002_pbc_28367 crossref_primary_10_1016_j_bbmt_2020_08_002 crossref_primary_10_1038_s41409_018_0217_2 crossref_primary_10_1080_17474086_2023_2273851 crossref_primary_10_1159_000531484 crossref_primary_10_53876_001c_117722 crossref_primary_10_6004_jnccn_2019_0024 crossref_primary_10_1016_j_leukres_2023_107326 crossref_primary_10_1016_j_clml_2020_06_010 crossref_primary_10_1200_JCO_19_02232 crossref_primary_10_1016_j_oraloncology_2021_105293 crossref_primary_10_1080_10428194_2020_1827252 crossref_primary_10_1016_j_clml_2022_06_006 crossref_primary_10_1177_10781552231225398 crossref_primary_10_1002_cncr_33175 crossref_primary_10_1016_j_jtct_2022_09_015 crossref_primary_10_1016_j_jtct_2023_07_013 crossref_primary_10_1016_j_clml_2021_06_022 crossref_primary_10_1182_bloodadvances_2022008572 crossref_primary_10_1186_s12885_019_6093_3 crossref_primary_10_1182_blood_2021012830 crossref_primary_10_1016_j_blre_2024_101169 crossref_primary_10_1007_s11912_022_01194_3 crossref_primary_10_3390_curroncol29080412 crossref_primary_10_1002_pbc_28263 crossref_primary_10_1016_j_bbmt_2020_09_013 crossref_primary_10_1001_jamanetworkopen_2024_1112 crossref_primary_10_1101_mcs_a005967 crossref_primary_10_1038_s41408_021_00533_0 crossref_primary_10_1097_MPH_0000000000002204 crossref_primary_10_1016_j_blre_2019_04_005 crossref_primary_10_1016_j_jtct_2023_03_007 crossref_primary_10_1016_j_blre_2018_08_002 crossref_primary_10_1016_j_jgo_2019_09_012 crossref_primary_10_1016_j_beha_2017_07_001 crossref_primary_10_1182_blood_2023023447 crossref_primary_10_3892_ol_2019_10649 crossref_primary_10_3390_ijerph17207526 crossref_primary_10_1016_j_bbmt_2019_02_009 crossref_primary_10_1016_j_bbmt_2018_03_016 crossref_primary_10_1016_j_jtct_2021_06_030 crossref_primary_10_1111_ejh_13752 crossref_primary_10_1002_cncr_33231 |
| Cites_doi | 10.1016/j.bbmt.2010.08.011 10.1038/bmt.2012.95 10.1016/j.bbmt.2009.12.529 10.1001/archpediatrics.2009.31 10.1182/blood-2002-12-3714 10.1016/j.leukres.2011.10.018 10.3324/haematol.2011.048348 10.1182/blood-2007-10-116582 10.1200/JCO.1997.15.7.2644 10.1038/bmt.2011.214 10.1002/cncr.25136 10.1093/aje/kwh090 10.1200/JCO.2003.06.178 10.1002/cncr.25297 10.1038/sj.bmt.1705975 10.6004/jnccn.2011.0028 10.1046/j.1365-2141.2002.03724.x 10.1016/j.leukres.2011.10.028 10.1001/jama.2009.813 10.1002/cncr.20628 10.1186/1471-2288-3-21 10.1016/j.bbmt.2013.10.004 10.1007/s00277-015-2351-x 10.1158/1055-9965.EPI-14-0963 10.1038/sj.bmt.1705464 10.1097/01.mlr.0000220830.46929.43 10.1097/01.dcr.0000436362.81611.de 10.1002/9781118548387 10.1002/cncr.21932 10.1023/A:1011240019516 10.1200/JCO.2013.49.6489 10.1016/j.annepidem.2015.01.008 10.1182/blood-2008-03-143115 10.1182/blood-2008-05-157065 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 Public Library of Science 2017 Jabo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 Jabo et al 2017 Jabo et al |
| Copyright_xml | – notice: COPYRIGHT 2017 Public Library of Science – notice: 2017 Jabo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 Jabo et al 2017 Jabo et al |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PIMPY PQEST PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0174760 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database (ProQuest) Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Biological Science Collection ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic Technology Collection Technology Research Database Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Statistics Public Health |
| DocumentTitleAlternate | Sociodemographic disparities in treatment utilization among adult acute leukemia patients |
| EISSN | 1932-6203 |
| Editor | Palaniyandi, Senthilnathan |
| Editor_xml | – sequence: 1 givenname: Senthilnathan surname: Palaniyandi fullname: Palaniyandi, Senthilnathan |
| EndPage | e0174760 |
| ExternalDocumentID | 1885095199 oai_doaj_org_article_19deef1393f143038a237a6769e4d243 A493764683 10_1371_journal_pone_0174760 28384176 |
| Genre | Journal Article |
| GeographicLocations | California La Jolla California United States--US Loma Linda California |
| GeographicLocations_xml | – name: California – name: La Jolla California – name: Loma Linda California – name: United States--US |
| GrantInformation_xml | – fundername: ; grantid: N01-PC-35139 – fundername: ; grantid: U58DP000807-01 – fundername: ; grantid: N01-PC-35136 – fundername: ; grantid: N02-PC-15105 |
| GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF D1I D1J D1K DIK DU5 E3Z EAP EAS EBD ECM EIF EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ NPM O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RIG RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX AFPKN CITATION 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PQEST PQUKI RC3 7X8 5PM AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c758t-98c90be1420fe38e24341388098420b16c20ab959dd9001f4bd1ff6813be7bb13 |
| IEDL.DBID | RPM |
| ISSN | 1932-6203 |
| IngestDate | Sun Aug 06 00:16:16 EDT 2023 Tue Oct 22 15:16:12 EDT 2024 Tue Sep 17 21:14:08 EDT 2024 Fri Oct 25 07:55:00 EDT 2024 Sat Nov 09 12:12:15 EST 2024 Thu Feb 22 23:26:41 EST 2024 Fri Feb 02 04:04:13 EST 2024 Thu Aug 01 19:47:56 EDT 2024 Thu Aug 01 19:14:55 EDT 2024 Tue Aug 20 22:11:20 EDT 2024 Fri Aug 23 01:07:07 EDT 2024 Tue Oct 15 23:55:44 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c758t-98c90be1420fe38e24341388098420b16c20ab959dd9001f4bd1ff6813be7bb13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceptualization: MJW BJ JWM MEM.Data curation: BJ JWM.Formal analysis: BJ JWM MG.Funding acquisition: JWM.Investigation: BJ.Methodology: BJ JWM MG MJW.Project administration: BJ JWM MJW.Resources: JWM.Software: JWM.Supervision: JWM MEM MJW.Validation: BJ MG.Visualization: BJ JWM MJW.Writing – original draft: BJ JWM MJW.Writing – review & editing: MEM MG. |
| ORCID | 0000-0002-5414-9228 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383052/ |
| PMID | 28384176 |
| PQID | 1885095199 |
| PQPubID | 1436336 |
| PageCount | e0174760 |
| ParticipantIDs | plos_journals_1885095199 doaj_primary_oai_doaj_org_article_19deef1393f143038a237a6769e4d243 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5383052 proquest_miscellaneous_1885952259 proquest_journals_1885095199 gale_infotracmisc_A493764683 gale_infotracacademiconefile_A493764683 gale_incontextgauss_ISR_A493764683 gale_incontextgauss_IOV_A493764683 gale_healthsolutions_A493764683 crossref_primary_10_1371_journal_pone_0174760 pubmed_primary_28384176 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-04-06 |
| PublicationDateYYYYMMDD | 2017-04-06 |
| PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-06 day: 06 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2017 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | 18827183 - Blood. 2009 Jan 1;113(1):28-36 21810970 - Haematologica. 2011 Aug;96(8):1083-6 16703597 - Cancer. 2006 Jun 15;106(12):2657-63 9215836 - J Clin Oncol. 1997 Jul;15(7):2644-51 21393441 - J Natl Compr Canc Netw. 2011 Mar;9(3):319-29; quiz 330 12139722 - Br J Haematol. 2002 Aug;118(2):385-400 15033648 - Am J Epidemiol. 2004 Apr 1;159(7):702-6 20628485 - J Oncol. 2010;2010:943823 20800103 - Biol Blood Marrow Transplant. 2010 Nov;16(11):1541-8 25662426 - Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):344-9 22112975 - Leuk Res. 2012 Feb;36(2):127 12714526 - Blood. 2003 Aug 15;102(4):1232-40 19509382 - JAMA. 2009 Jun 10;301(22):2349-61 20564092 - Cancer. 2010 Jul 15;116(14):3447-57 11562110 - Cancer Causes Control. 2001 Oct;12(8):703-11 18209726 - Bone Marrow Transplant. 2008 Mar;41(5):415-23 20564154 - Cancer. 2010 Jul 15;116(14):3469-76 20036337 - Biol Blood Marrow Transplant. 2010 Aug;16(8):1070-5 22112974 - Leuk Res. 2012 Feb;36(2):140-5 25791241 - Ann Hematol. 2015 Jul;94(7):1127-38 22056642 - Bone Marrow Transplant. 2012 Nov;47(11):1385-90 15484218 - Cancer. 2004 Nov 15;101(10):2230-8 24201389 - Dis Colon Rectum. 2013 Dec;56(12):1357-65 20837332 - Best Pract Res Clin Haematol. 2010 Jun;23(2):207-16 12663717 - J Clin Oncol. 2003 Apr 1;21(7):1293-300 18519812 - Blood. 2008 Aug 1;112(3):903-9 25794765 - Ann Epidemiol. 2015 Apr;25(4):250-5 18048644 - Blood. 2008 Feb 15;111(4):1827-33 16892073 - Bone Marrow Transplant. 2006 Oct;38(7):467-75 17001267 - Med Care. 2006 Oct;44(10):952-5 14567763 - BMC Med Res Methodol. 2003 Oct 20;3:21 24120525 - Biol Blood Marrow Transplant. 2014 Jan;20(1):53-7 22705801 - Bone Marrow Transplant. 2013 Jan;48(1):63-7 24062405 - J Clin Oncol. 2013 Nov 1;31(31):3869-76 19414690 - Arch Pediatr Adolesc Med. 2009 May;163(5):438-45 AJ Barros (ref30) 2003; 3 AA Aizer (ref35) 2013; 31 ref34 AH Goldstone (ref2) 2008; 111 MI Patel (ref16) 2015; 24 A Ruggeri (ref18) 2010; 23 DI Marks (ref19) 2006; 38 ref31 ref39 JM Mitchell (ref10) 1997; 15 R Ram (ref4) 2010; 116 JK Chan (ref45) 2006; 44 MM Cho (ref44) 2013; 56 AK Burnett (ref6) 2002; 118 AG Fritz (ref25) 2000 S Suciu (ref5) 2003; 102 TV Joshua (ref15) 2010; 116 S Saghari (ref43) 2015; 25 JN Barker (ref20) 2010; 16 J Koreth (ref7) 2009; 301 LD Eleni (ref36) 2010 BC Medeiros (ref38) 2015; 94 ref24 JZ Ayanian (ref46) 2003; 21 B Gyurkocza (ref21) 2011; 9 JP Hwang (ref14) 2004; 101 MH Kutner (ref33) 2004 NS Majhail (ref17) 2012; 47 ref42 DW Hosmer (ref32) 2013 ref41 CF Craddock (ref22) 2008; 41 P Cummings (ref28) 2009; 163 GG Laport (ref1) 2008; 112 J Pidala (ref9) 2013; 48 ref27 K Yost (ref26) 2001; 12 BC Medeiros (ref12) 2012; 36 NS Majhail (ref11) 2010; 16 J Bierenbaum (ref13) 2012; 36 MA Sekeres (ref8) 2009; 113 JM Ribera (ref23) 2011; 96 M Yanada (ref3) 2006; 106 G Zou (ref29) 2004; 159 ref40 BK Ragon (ref37) 2014; 20 |
| References_xml | – volume: 16 start-page: 1541 issue: 11 year: 2010 ident: ref20 article-title: Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities publication-title: Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation doi: 10.1016/j.bbmt.2010.08.011 contributor: fullname: JN Barker – ident: ref39 – volume: 48 start-page: 63 issue: 1 year: 2013 ident: ref9 article-title: Practice variation in physician referral for allogeneic hematopoietic cell transplantation publication-title: Bone marrow transplantation doi: 10.1038/bmt.2012.95 contributor: fullname: J Pidala – volume: 16 start-page: 1070 issue: 8 year: 2010 ident: ref11 article-title: Access to hematopoietic cell transplantation in the United States publication-title: Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation doi: 10.1016/j.bbmt.2009.12.529 contributor: fullname: NS Majhail – volume: 163 start-page: 438 issue: 5 year: 2009 ident: ref28 article-title: The relative merits of risk ratios and odds ratios publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpediatrics.2009.31 contributor: fullname: P Cummings – volume: 102 start-page: 1232 issue: 4 year: 2003 ident: ref5 article-title: Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial publication-title: Blood doi: 10.1182/blood-2002-12-3714 contributor: fullname: S Suciu – volume: 36 start-page: 140 issue: 2 year: 2012 ident: ref13 article-title: Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience publication-title: Leukemia research doi: 10.1016/j.leukres.2011.10.018 contributor: fullname: J Bierenbaum – volume: 96 start-page: 1083 issue: 8 year: 2011 ident: ref23 article-title: Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how publication-title: Haematologica doi: 10.3324/haematol.2011.048348 contributor: fullname: JM Ribera – volume: 111 start-page: 1827 issue: 4 year: 2008 ident: ref2 article-title: In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) publication-title: Blood doi: 10.1182/blood-2007-10-116582 contributor: fullname: AH Goldstone – volume: 15 start-page: 2644 issue: 7 year: 1997 ident: ref10 article-title: Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology doi: 10.1200/JCO.1997.15.7.2644 contributor: fullname: JM Mitchell – ident: ref41 – volume: 47 start-page: 1385 issue: 11 year: 2012 ident: ref17 article-title: Racial disparities in hematopoietic cell transplantation in the United States publication-title: Bone marrow transplantation doi: 10.1038/bmt.2011.214 contributor: fullname: NS Majhail – year: 2004 ident: ref33 article-title: Applied linear regression models contributor: fullname: MH Kutner – volume: 116 start-page: 3447 issue: 14 year: 2010 ident: ref4 article-title: Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis publication-title: Cancer doi: 10.1002/cncr.25136 contributor: fullname: R Ram – ident: ref24 – volume: 159 start-page: 702 issue: 7 year: 2004 ident: ref29 article-title: A modified poisson regression approach to prospective studies with binary data publication-title: American journal of epidemiology doi: 10.1093/aje/kwh090 contributor: fullname: G Zou – volume: 21 start-page: 1293 issue: 7 year: 2003 ident: ref46 article-title: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology doi: 10.1200/JCO.2003.06.178 contributor: fullname: JZ Ayanian – volume: 116 start-page: 3469 issue: 14 year: 2010 ident: ref15 article-title: Access to hematopoietic stem cell transplantation: effect of race and sex publication-title: Cancer doi: 10.1002/cncr.25297 contributor: fullname: TV Joshua – volume: 41 start-page: 415 issue: 5 year: 2008 ident: ref22 article-title: Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML publication-title: Bone marrow transplantation doi: 10.1038/sj.bmt.1705975 contributor: fullname: CF Craddock – volume: 9 start-page: 319 issue: 3 year: 2011 ident: ref21 article-title: Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantation publication-title: Journal of the National Comprehensive Cancer Network: JNCCN doi: 10.6004/jnccn.2011.0028 contributor: fullname: B Gyurkocza – ident: ref27 – volume: 118 start-page: 385 issue: 2 year: 2002 ident: ref6 article-title: The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial publication-title: British journal of haematology doi: 10.1046/j.1365-2141.2002.03724.x contributor: fullname: AK Burnett – start-page: 2010 year: 2010 ident: ref36 article-title: Challenges in Treating Older Patients with Acute Myeloid Leukemia publication-title: Journal of Oncology contributor: fullname: LD Eleni – volume: 36 start-page: 127 issue: 2 year: 2012 ident: ref12 article-title: "It doesn't matter if you're black or white", does it? publication-title: Leukemia research doi: 10.1016/j.leukres.2011.10.028 contributor: fullname: BC Medeiros – volume: 301 start-page: 2349 issue: 22 year: 2009 ident: ref7 article-title: Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials publication-title: Jama doi: 10.1001/jama.2009.813 contributor: fullname: J Koreth – volume: 101 start-page: 2230 issue: 10 year: 2004 ident: ref14 article-title: Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas publication-title: Cancer doi: 10.1002/cncr.20628 contributor: fullname: JP Hwang – ident: ref34 – volume: 3 start-page: 21 year: 2003 ident: ref30 article-title: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio publication-title: BMC medical research methodology doi: 10.1186/1471-2288-3-21 contributor: fullname: AJ Barros – year: 2000 ident: ref25 article-title: International classification of diseases for oncology: ICD-O contributor: fullname: AG Fritz – volume: 20 start-page: 53 issue: 1 year: 2014 ident: ref37 article-title: Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy publication-title: Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation doi: 10.1016/j.bbmt.2013.10.004 contributor: fullname: BK Ragon – volume: 94 start-page: 1127 issue: 7 year: 2015 ident: ref38 article-title: Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States publication-title: Annals of Hematology doi: 10.1007/s00277-015-2351-x contributor: fullname: BC Medeiros – volume: 24 start-page: 344 issue: 2 year: 2015 ident: ref16 article-title: How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia? publication-title: Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research doi: 10.1158/1055-9965.EPI-14-0963 contributor: fullname: MI Patel – volume: 38 start-page: 467 issue: 7 year: 2006 ident: ref19 article-title: Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options publication-title: Bone marrow transplantation doi: 10.1038/sj.bmt.1705464 contributor: fullname: DI Marks – volume: 44 start-page: 952 issue: 10 year: 2006 ident: ref45 article-title: Validity of cancer registry medicaid status against enrollment files: implications for population-based studies of cancer outcomes publication-title: Medical care doi: 10.1097/01.mlr.0000220830.46929.43 contributor: fullname: JK Chan – volume: 56 start-page: 1357 issue: 12 year: 2013 ident: ref44 article-title: Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994–2009 publication-title: Diseases of the colon and rectum doi: 10.1097/01.dcr.0000436362.81611.de contributor: fullname: MM Cho – year: 2013 ident: ref32 article-title: Applied logistic regression doi: 10.1002/9781118548387 contributor: fullname: DW Hosmer – ident: ref42 – ident: ref40 – volume: 106 start-page: 2657 issue: 12 year: 2006 ident: ref3 article-title: Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis publication-title: Cancer doi: 10.1002/cncr.21932 contributor: fullname: M Yanada – volume: 12 start-page: 703 issue: 8 year: 2001 ident: ref26 article-title: Socioeconomic status and breast cancer incidence in California for different race/ethnic groups publication-title: Cancer causes & control: CCC doi: 10.1023/A:1011240019516 contributor: fullname: K Yost – volume: 31 start-page: 3869 issue: 31 year: 2013 ident: ref35 article-title: Marital status and survival in patients with cancer publication-title: Journal of clinical oncology: official journal of the American Society of Clinical Oncology doi: 10.1200/JCO.2013.49.6489 contributor: fullname: AA Aizer – volume: 25 start-page: 250 issue: 4 year: 2015 ident: ref43 article-title: Sociodemographic predictors of delayed- versus early-stage cervical cancer in California publication-title: Ann Epidemiol doi: 10.1016/j.annepidem.2015.01.008 contributor: fullname: S Saghari – volume: 112 start-page: 903 issue: 3 year: 2008 ident: ref1 article-title: Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen publication-title: Blood doi: 10.1182/blood-2008-03-143115 contributor: fullname: GG Laport – volume: 23 start-page: 207 issue: 2 year: 2010 ident: ref18 article-title: Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors? Best practice & research publication-title: Clinical haematology contributor: fullname: A Ruggeri – volume: 113 start-page: 28 issue: 1 year: 2009 ident: ref8 article-title: Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients publication-title: Blood doi: 10.1182/blood-2008-05-157065 contributor: fullname: MA Sekeres – ident: ref31 |
| SSID | ssj0053866 |
| Score | 2.4919434 |
| Snippet | Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and... Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia... INTRODUCTIONIdentifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia... Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia... |
| SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e0174760 |
| SubjectTerms | Acute lymphoblastic leukemia Acute myelocytic leukemia Acute myeloid leukemia Acute promyeloid leukemia Adolescent Adult Age Aged Analysis Antineoplastic Agents - therapeutic use Arches Autografts Availability Binary data Blood Breast cancer Cadmium Cancer Cancer therapies Care and treatment Census Census of Population Cervical cancer Cervix Chemotherapy Classification Clinical trials Colon Colorectal carcinoma Combined Modality Therapy Complications Computation Computer programs Conditioning Constrictions Control Demography Diagnosis Diseases Donors Epidemiology Estimates Ethnic factors Ethnicity Female Females Government programs Health care Health care disparities Health risk assessment Health surveillance Hematology Hematopoietic Stem Cell Transplantation Hispanic people Historical account Humans Incidence Income Leukemia Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - therapy Lymphatic leukemia Male Males Marital status Medicaid Medical research Medicine and Health Sciences Middle Aged Minority & ethnic groups Myeloid leukemia Older people Oncology People and Places Population studies Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Promyeloid leukemia Public health Radiation Radiation therapy Receiving Rectum Regression analysis Risk Social Class Social Sciences Sociodemographics Socioeconomic factors Socioeconomics Statistics Stem cell transplantation Stem cells Studies Transplantation Transplants & implants Utilization Young Adult |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZQT1wQy2sLCxiEBByyGzvOw8cFsVqQAAlYtLfIrywRaVKR9tDfwx9lxnbLBq0EB67x1Gr9jWc-pzOfCXnGFGsMNzbRsoQDCpyqE9XIIikBbC24ziXDRuH3H4rTM_HuPD-_dNUX1oQFeeCwcEdMWuca4ClZA6k9zSrFs1JhYaYTloug85nK7WEqxGDYxUURG-Wykh1FXA6XQ-8OwQdF6SUpfycir9e_i8qzZTeMV1HOPysnL6Wik5vkRuSQ9Dh89z1yzfW3yF7cpSN9EaWkX94mP30_inWLIEzdGmrbEe8dRBlV2vYUIFvEHqwNVb2lXsN1WA4tNjdSfK1PV17_vFOhSamn4Kpd7N6k_q4i6kU8qDLrlaPdBvxj0EDKcQKcMjxfbFw3tJZ2bv3dLVpFo6LreIecnbz58vo0idcyJAYOF6tEVkam2jHB08ZllQMQIBNCHJAVPNKsMDxVWubSWglJsBHasqYpKpZpV2rNsrtk1gMQ-4QWTDW5sIxzZ0QpDbDVNFVcm9xwkdt8TpItRvUyqG_U_i-4Ek4tYbFrxLSOmM7JKwRyZ4va2f4BeFQdPar-m0fNyWN0gzo0ou4iQH0sgMoVoqjA4qm3QP2MHgt0LtR6HOu3H7_-g9HnTxOj59GoGQBNo2JTBPwm1OWaWB5MLCEKmMnwPjrtdlXGmlVVjvRZSvjk1pGvHn6yG8ZJseiud8M62Ejg5znY3At-v1tZYKWVYGUxJ-VkR0yWfjrSt9-8fDlsTkgy_P7_wOoBuc6RZ2EpVXFAZqsfa_cQWOJKP_IB4RePl2hN priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZguVRCiJZHFwoYhAQc0saJ8_AJlYqqIAESUNRb5FdKRDZZmt3D_h7-KDO2d0tQhbjaEyvxeGY-OzOfCXnOJKt1ok2kRAEbFNhVR7IWeVSAshVPVCYYFgp_-JifnPL3Z9lZOHAbQlrl2ic6R216jWfkB6wsM4QDQrye_4zw1ij8uxqu0LhObjCIc5jSVx5tUjzAlvM8lMulBTsI2tmf953dh5XIC0dMeRmOHGv_xjdP5m0_XAU8_86f_CMgHd8mtwKSpIde9dvkmu12yE1_DEd9ddEO2Q62O9CXgWD61Q7ZQoTpCZrvkF-uZMXYmeeuhmdNM-DVhMi0SpuOglZnoUxrRWVnqKN57ed9g_WPFE_-6cJRpLfS1zF1FFZzGwo8qbvOiDqeDyr1cmFpu4Il1CvA7TgADunbZyvb9o2hrV3-sLNG0kD6Otwlp8dvvx6dROHmhkjD_mMRiVKLWFnGk7i2aWkTjsESXIUooUmxXCexVCITxgiIkzVXhtV1XrJU2UIplt4jkw60tEtozmSdcQPqtZoXQgOgjWOZKJ3phGcmm5JorcBq7gk6KveXroCNjddEhQqvgsKn5A1qeSOL9Nquob84r4K1VkwYa2sAx2kNeDJOS5mkhcRsYMsNfMyUPME1Uvla1Y2TqA45oL2c5yVIPHMSSLHRYQ7PuVwOQ_Xu07f_EPryeST0IgjVPWhTy1A3Ad-E1F0jyb2RJDgKPerexRW9npWhujQpeHK9yq_ufrrpxkExL6-z_dLLCIDwGcjc90axmVkAriVnRT4lxchcRlM_7uma747hHCwX4lDy4N-v9ZBsJQiyMI8q3yOTxcXSPgKIuFCPnR_4DcC4aeY priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_H-uKLeH7dnqdGEdSHLk2afuRB5BSPU1BBXbm3kqTpWey263YX3L_Hf9SZNFusrHCvzTTQzEzym2bmN4Q8ZYqVhpsi0DKFAAWi6kCVMglSULYWXMeSYaHwh4_J-Vy8v4gvDsiuZ6tfwG5vaIf9pOarevbr5_YVOPxL17UhZbuXZsu2sTOwMJEmEMRf4wJidUzmE8O9Ani3u71E1BIkPIx8Md3_ZhkdVo7Tf9i5J8u67fbB0n-zK_86rs5ukhseZ9LT3jAOyYFtbpFD78kdfe7ppl_cJr9dzUphFz15dWVoUXXYmxCpVmnVUFDrwtdpbalqCup4XttlW2EBJMVf_3TtONJr1RcyNRTMufYVntT1M6KO6IMqs1lbWm_BhloNwB0nwCn754utrduqoLXd_LCLSlHP-trdIfOzt1_fnAe-dUNgIABZBzIzMtSWCR6WNsos6AJOS9grZAaPNEsMD5WWsSwKCQdlKXTByjLJWKRtqjWL7pJJA4o4IjRhqoxFwTi3RqTSAKINQ8W1iQ0XcRFPSbDTUb7sGTpyd02XQmTTL3aOOs29TqfkNSpykEV-bfegXV3m3l1zJgtrS0DHUQmAMowyxaNUYTqwFQV8zJQ8QjPI-2LVYZfITwXAvUQkGUg8cRLIsdFgEs-l2nRd_u7TtysIffk8EnrmhcoWtGmUL5yAb0LurpHkyUgSdgozGj5Co92tSpezLIsRYksJb-4Mef_w42EYJ8XEvMa2m15GAoaPQeZeb_fDygJyzQRLkylJRx4xWvrxSFN9dxTn4KhwEPHjqyzifXKdI9bCdKrkhEzWq419AEhxrR865_8DPE9qhA priority: 102 providerName: Scholars Portal |
| Title | Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28384176 https://www.proquest.com/docview/1885095199 https://search.proquest.com/docview/1885952259 https://pubmed.ncbi.nlm.nih.gov/PMC5383052 https://doaj.org/article/19deef1393f143038a237a6769e4d243 http://dx.doi.org/10.1371/journal.pone.0174760 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2cuGCGF8rjGIQEnBIWyfOh49btTGQOqbB0G6R7ThbRJpUS3vo38M_ynuOUy1oB8TFB_vFavw-_HP63s-EvGeS5drXmadEDAcUOFV7MheRF4OyFfdVKBgWCs_PotNL_vUqvNohYVcLY5P2tSrGVbkYV8WNza1cLvSkyxObnM9n4KRgpv5kl-yCgXZH9Db8wlgUuRq5IGYTp5Lxsq7MGMyPxxHe_ga7asIZMo3c2Y4sa_82Ng-WZd3cBzz_zp-8syGdPCaPHJKkh-0v3iM7pnpC9pyvNvSjI5T-9JT8tlUpmVm09NSFplnR4O2DSKZKi4qC4hauEmtDZZVRy-RaL-sCSxwpftynK8uCXsq2VKmiYLClq-Gk9sYiaqk8qNTrlaHlBqykVgDNcQKcsu1fbExZFxktzfqXWRSSOl7X5hm5PDn-MTv13OUMnoYjxsoTiRZTZRj3p7kJEuNz3A8hGogEuhSLtD-VSoQiywRshTlXGcvzKGGBMrFSLHhOBhXoZJ_QiMk85BnzfaN5LDRg1ulU-kqH2udhFg6J1-koXbYcHKn9Iy6Gs0u72CmqN3XqHZIjVORWFhm0bUd9e506O0qZyIzJAf8GOUDGaZBIP4glJvwansHLDMkbNIO0LUfdxoH0kAOgi3iUgMQ7K4EsGhWm6VzLddOkX779_Aeh7xc9oQ9OKK9Bm1q60gh4J2Tn6kke9CQhFuje8D4abbcqTcqSJEQQLQQ82Rny_cNvt8M4KabeVaZetzICUHoIMi9au9-ubOdFQxL3PKK39P0R8GlLYu58-OV_P_mKPPQRYmEWVXRABqvbtXkNAHGlRhAWrmJokxnD9uTziDw4Oj47vxjZTy7QznkysmHjD5r2b7o |
| link.rule.ids | 230,315,730,783,787,867,888,2109,2228,12068,12235,12777,21400,24330,27936,27937,31731,31732,33278,33279,33385,33386,33756,33757,43322,43591,43612,43817,53804,53806,74073,74342,74363,74630 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegPDAJIVY-VhjMICTgIVucOB9-QgNROtiGBNu0t8hfGRVtUpb2oX8P_yh3jtsRNCFe7YuV-Hx3Pzt3PxPykklW6kibQIkMNiiwqw5kKdIgA2UrHqlEMCwUPjpOR6f803ly7g_cGp9WufKJzlGbWuMZ-R7L8wThgBBvZz8DvDUK_676KzRukls8hliNleLDjytPDLacpr5cLs7YntfO7qyu7C6sRJ45YsqrcORY-9e-uTeb1M11wPPv_Mk_AtLwHrnrkSTdb1W_SW7Yqk_utMdwtK0u6pNNb7sNfe0Jpt_0yQYizJag-T755UpWjJ223NXwrBk3eDUhMq3ScUVBq1NfprWksjLU0bzWs3qM9Y8UT_7p3FGkT2Rbx1RRWM0TX-BJ3XVG1PF8UKkXc0snS1hCtQLcjgPgkG37dGkn9djQiV38sNOxpJ70tXlATocfTt6PAn9zQ6Bh_zEPRK5FqCzjUVjaOLcRx2AJrkLk0KRYqqNQKpEIYwTEyZIrw8oyzVmsbKYUix-SXgVa2iI0ZbJMuGFRZDXPhAZAG4YyUjrREU9MMiDBSoHFrCXoKNxfugw2Nq0mClR44RU-IO9Qy2tZpNd2DfXlReGttWDCWFsCOI5LwJNhnMsoziRmA1tu4GMGZAfXSNHWqq6dRLHPAe2lPM1B4oWTQIqNCnN4LuSiaYqDL2f_IfTta0folRcqa9Cmlr5uAr4Jqbs6ktsdSXAUutO9hSt6NStNcWVS8ORqlV_f_XzdjYNiXl5l60UrIwDCJyDzqDWK9cwCcM05y9IByTrm0pn6bk81_u4YzsFyIQ5Fj__9Wjvk9ujk6LA4PDj-_IRsRAi4MKcq3Sa9-eXCPgW4OFfPnE_4DU1ObQU |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLagSGgSQqxcVhjMICTgIWudOBc_oTGYNi4DAUN7i3zLqEiTsrQP_T38Uc5x3IygCfFqn1iJz8Wf43M-E_KUSVboUJtAiRQ2KLCrDmQhkiAFZSseqlgwLBT-cJwcnvC3p_Gpz39qfFrlOia6QG1qjf_IxyzLYoQDQowLnxbx6fXBy_nPAG-QwpNWf53GVXINVkWOtxlk-126B_h1kvjSuShlY6-p3Xld2V2wSp46ksqLpckx-HdxejAv6-YyEPp3LuUfi9PBLXLTo0q615rBJrliqyG50f6So22l0ZBsej9u6HNPNv1iSDYQbbZkzbfJL1e-Yuys5bGGZ820wWsKkXWVTisKGp75kq0VlZWhjvK1ntdTrIWkeApAF44uvZRtTVNFwbJLX-xJ3dVG1HF-UKmXC0vLFZhTrQDD4wA4ZNs-W9mynhpa2uUPO5tK6glgmzvk5ODN1_3DwN_iEGjYiywCkWkxUZbxcFLYKLMhx4UTwobIoEmxRIcTqUQsjBGwZhZcGVYUScYiZVOlWHSXDCrQ0hahCZNFzA0LQ6t5KjSA28lEhkrHOuSxiUckWCswn7dkHbk7sUthk9NqIkeF517hI_IKtdzJItW2a6jPz3LvuTkTxtoCgHJUALacRJkMo1RiZrDlBj5mRHbQRvK2brULGPkeB-SX8CQDiSdOAuk2KjTcM7lsmvzo47f_EPryuSf0zAsVNWhTS19DAd-ENF49ye2eJAQN3eveQotez0qTX7gXPLm28su7H3fdOCjm6FW2XrYyAuB8DDL3WqfoZhZAbMZZmoxI2nOX3tT3e6rpd8d2Dp4La1J4_9-vtUOuQzjI3x8dv3tANkLEXphelWyTweJ8aR8CclyoRy4k_AYOOHEI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sociodemographic+disparities+in+chemotherapy+and+hematopoietic+cell+transplantation+utilization+among+adult+acute+lymphoblastic+and+acute+myeloid+leukemia+patients&rft.jtitle=PloS+one&rft.au=Jabo%2C+Brice&rft.au=Morgan%2C+John+W&rft.au=Martinez%2C+Maria+Elena&rft.au=Ghamsary%2C+Mark&rft.date=2017-04-06&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=12&rft.issue=4&rft.spage=e0174760&rft_id=info:doi/10.1371%2Fjournal.pone.0174760&rft.externalDBID=IOV&rft.externalDocID=A493764683 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |